Search

everythinglearnresearchcommunity

for

Search:↓

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Spironolactone plus finasteride reduces hirsutism more effectively.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Finasteride shows promise for female hair loss, but more research needed.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.